Table 1. The characteristics of patients (n = 64)

Age (mean ± SD and range)63.1 ± 6.3 years (48 – 76)
Total PSA (Median (min-max))7.7 ng/ml (2.1 – 57 ng/ml)
PSA density (Median (min-max))18.3 ng/ml/cc (3.6 – 132.0 ng/ml/cc)
Free to total PSA ratio (Median (min-max))13.5 % (4.0 %– 39.4 %)
PIRADS Scores (N-%)1 (1-1.6%), 2 (7-10.9%), 3 (8-12.5%), 4 (26-40.6%), 5 (22-34.4%)
miPSMA scores (N-%)0 (10-15.6%), 1 (21-32.8%), 2 (23-35.9%), 3 (10-15.6%)
Gleason scores (N-%)6 (9-14.1%), 7 (38-59.4%), 8 (5-7.8%), 9 (9-14.1%), 10 (3-4.7%)
Gleason grades (N-%)1 (9-14.1%), 2 (28-43.8%), 3 (10-15.6%), 4 (5-7.8%), 5 (12-18.8%)
D’amico risk groups (N-%)Low-intermediate risk(26-40.6%), High risk(38-59.4%)